Mediterranean diet may delay Alzheimer's

There’s a mountain of evidence showing that the traditional Mediterranean diet reduces the risk of heart disease, but a new UCLA study suggests that it can slow the progression of Alzheimer’s as well.

Led by Assistant Clinical Professor David A. Merrill, MD, PhD, the study is the first to show that a Mediterranean diet combined with exercise can reduce the buildup of beta-amyloid and tau proteins in individuals with mild memory problems.

"The fact that we could detect this influence of lifestyle at a molecular level before the beginning of serious memory problems surprised us," says Dr. Merrill.

The study examined nearly 50 patients from 40 to 85 years old. Twenty-four subjects had subjective (self-reported) memory impairment and 20 reported mild cognitive impairment (MCI). The individuals reported their BMI, physical activity levels and the extent to which they followed a Mediterranean diet. The patients then underwent a novel PET scan called FDDNP-PET, which measures the levels of beta-amyloid and tau proteins in the brain.

The team found that those who had a healthy BMI, engaged in regular physical activity and followed a Mediterranean diet had lower levels of tangles and plaques in their brains than subjects who did not adhere to these behaviors.

"The study reinforces the importance of living a healthy life to prevent Alzheimer's, even before the development of clinically significant dementia. This work lends key insight not only into the ability of patients to prevent Alzheimer's disease, but also physicians' ability to detect and image these changes,” wrote Merrill et al.

As a Senior Writer for TriMed Media Group, Will covers radiology practice improvement, policy, and finance. He lives in Chicago and holds a bachelor’s degree in Life Science Communication and Global Health from the University of Wisconsin-Madison. He previously worked as a media specialist for the UW School of Medicine and Public Health. Outside of work you might see him at one of the many live music venues in Chicago or walking his dog Holly around Lakeview.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.